Company intelligence / Profile preview

chAIron

Ownership: Private
Development stage: Other

Overview

chAIron provides advanced AI-powered services to pharmaceutical and biotech companies by identifying new therapeutic indications for both shelved/failed assets and marketed drugs. Their approach combines real-world data, omics data, literature mining, artificial intelligence, clinical expertise, and business analytics to maximize the value of drug assets. They do not develop their own therapeutics but act as a strategic partner in R&D decision-making.

Modalities: Varies by project/client
Industry: Drug Discovery Services

Partnerships

Collaborates with pharma companies seeking new uses for shelved or commercialized assetsworks with biotechs in early development stages

Beyond the preview

Go deeper on chAIron.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on chAIron.

Explore the full profile